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It is now becoming widely recognized that there are important sex differences in disease. These include rates of
disease incidence, symptoms and age of onset. These differences between the sexes can be seen as a subset of
the more general phenomenon of sexual dimorphism of quantitative phenotypes. From a genetic point of view,
this is paradoxical, since the vast majority of genetic material is shared between the sexes. How can males and
females differ in so many ways and yet have a common genetic code? Traditionally, the modifying action of
hormones has been offered as a solution to this paradox, but experiments disentangling the effects of hormones
and sex-chromosomes have shown that this cannot be the sole explanation. In this review, I outline current ideas
about the evolutionary origins of sex differences in phenotypes, with a particular focus on how sex differences in
disease can arise. I also discuss how sex differences in themselves can generate new risk factors for disease, in effect
becoming a new environmental factor, as well as briefly reviewing more general evidence for sexually antagonistic
selection and genetic variation within humans. Taking an evolutionary view on sex differences in disease provides
an opportunity for greater understanding of mechanisms of disease and as such provides a clear motivation for
clinicians to explore how therapies may be tailored to the individual in a sex-dependent way.
Keywords: Sexual dimorphism, Sex-specific genetic architecture, Sex-chromosomes, Evolutionary medicine,
Darwinian medicine, Sexual selection, Natural selection, Personalized medicine, Gender medicineReview
Introduction
In the inaugural article of Biology of Sex Differences [1],
Arnold outlined the main motivations for why the exist-
ence of separate sexes is an important factor to consider
when investigating human disease, the key point is that sex
differences in human physiology exist and that they matter,
both in terms of determining disease phenotypes and also
for shaping more effective therapies. Biomedical scientists
have traditionally ignored the importance of phenotypic
differences between males and females [1], although this is
changing [2]. The NIH, for example, recently announced it
will be developing its policies to pay attention to sex differ-
ences in preclinical research [3], which is likely to result in
considerable benefits should prospective gender-specific
therapies be implemented [4].
The effect of sex on disease can be manifest in many
ways, including the presentation of the disease and its
associated symptoms, the prevalence or age of onset. ACorrespondence: ted.morrow@sussex.ac.uk
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unless otherwise stated.review by Ober et al. [5] emphasized that although some
sex differences are due to classical differences in circulat-
ing hormones, there is increasing evidence that genetic
factors make an important contribution. This is illustrated
for example by data from the ‘four core genotypes’ model,
where hormonal and sex chromosome contributions to
phenotypic differences between the sexes can be disen-
tangled from one another [6].
Identifying specific cases of how males and females differ
biologically is important therapeutically, but in order for
biologists and physicians to gain a full understanding, it is
necessary to appreciate how these differences came about
[1,7]. Evolutionary theory can provide useful insights into
the origins of sex differences, either as adaptations in their
own right in the case of physiological differences or in
explaining why pathogenic phenotypes persist in a popula-
tion [7,8].
From an evolutionary standpoint, sex differences in
disease can be seen as a subset of the more general
phenomenon of sexual dimorphism of quantitative traits,
including important life-history traits such as ageing and
longevity [9]. It is the ultimate causes and consequences
of sexual dimorphism that I explore in this review, withis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain






Figure 1 Bateman gradients. For males, fitness (in terms of
reproductive output) is a simple linear function of the number of
matings (or investment made in reproduction). For females however,
the function is one of diminishing returns as fitness reaches a limit,
at least over the short term, at an intermediate number of matings.
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notypes. The aim is to provide a researcher working at
the front line of human physiology and disease with a
clearer understanding of how sex differences evolve and
to explore some of the ways in which sex differences can
create novel selective pressures, generating further evo-
lutionary change.
The evolution of sexual dimorphism
Evolutionary biologists have long wondered why males
and females are different. Darwin’s ‘other book’ The
Descent of Man catalogs the multitude of ways in which
males and females of many different species differ from
one another in terms of their morphology and behav-
iour [10], although not explicitly their physiology. In
that volume, Darwin also proposed a mechanism for
evolutionary change, his theory of sexual selection, and
ascribes this force as the origin for many of the records
of differences in ‘secondary sexual characters’. Sexual
selection theory is fundamentally grounded in the idea
that reproductive success varies amongst individuals
within a population, and this drives the evolution of
traits that maximize reproductive success over the course
of an individual’s lifetime [11]. Classic examples of this
come from several species of large mammals, such as the
elephant seal, where male reproductive success is highly
skewed; a few individuals siring the majority of the off-
spring in any 1 year. The skewed distribution in male re-
productive success depends to a large extent on traits
such as size of ornaments or weapons or overall body
size [11].
Sexual selection is a likely driving force for many ex-
amples of sexual dimorphism, particularly the weaponry
and display traits that Darwin was interested in. But for
other traits not used in male-male competition or mate
choice, the explanation is less obvious. The mechanisms
by which traits become sexually dimorphic, whether via
sexual or natural selection, are still not fully resolved,
although evolutionary models have been proposed based
on sex-specific differences in selection and changes to
the genetic architecture [12]. Essentially, differences in
selection experienced by the two sexes are rooted in an-
isogamy (unequal gamete size). This as most fundamen-
tal of all sexual dimorphisms sets the stage for unequal
investment by the two sexes in reproduction. Female re-
productive success is limited by resource availability and
acquisition, whereas male reproductive success is limited
by access to mates and the number of fertilizations and
may therefore be more variable. One way of visualizing
this is to plot so-called Bateman gradients for the two
sexes (Figure 1; named after the biologist A. J. Bateman
who first studied them [13])—these show how fitness
changes for each sex in terms of reproductive output as
a function of number of matings.Males and females maximize their lifetime reproduct-
ive success by employing different life-history strategies,
and as a result, natural selection can act on shared traits
in sex-specific ways. In some cases, the selection acting
on shared traits may be so divergent that they are in op-
posite directions, this form of selection is termed sexually
antagonistic selection [14]. For the genetic loci underlying
any given shared trait, there may be intralocus sexual con-
flict (IASC) over which alternative alleles are favoured by
selection in the two sexes [15]. At a genome-wide scale,
there is now clear evidence that IASC exists in a variety of
taxa [16]. It should be noted that although selection may
operate in opposite directions in the two sexes, IASC is
only realized when the intersexual genetic correlation for
the trait (rMF) is in the opposite direction to selection [17].
Furthermore, the strength of the genetic correlation
between the sexes can be taken as an indication of how
readily sexual dimorphism will evolve, given diverging
or opposing selection [12], (see below).
According to sex-specific or sexually antagonistic models
of evolutionary change, the evolution of sexual dimorphism
can be broken down into four conceptually distinct stages
[18]; see Figure 2a–d. The first stage is when a shared trait
is in its ancestral monomorphic state (Figure 2a). While it
is possible that newly emerging traits or new mutations
can have directly sex-limited phenotypes (e.g. Y-linked loci,
or traits derived from or associated with those already sex-
limited), for the majority of cases, it is likely that they are
manifest in both sexes. As a result, in this first phase, it is
also likely that the genetic correlation between the sexes
for any given novel trait is positive.
A trait will remain in a sexually monomorphic state
unless selection acting on it becomes sex-specific,
which could be caused, for example, by a change in




















































Figure 2 Evolution of sexual dimorphism over four stages. Each panel shows the frequency distribution of trait values for a hypothetical
population (females (red), males (blue), overlap (purple)) and fitness surfaces (solid lines). Mean phenotypic trait values given by dashed vertical
lines, optimum trait values given by asterisks, where fitness is maximized. (a) The trait experiences stabilizing selection to a single optimum trait
value and the trait is sexual monomorphic; (b) the trait experiences sex-specific selection (red and blue fitness surfaces and optima) but is sexually
monomorphic. As a consequence the population experiences a gender load (sum of Δf and Δm), which is the difference between the maximum
possible fitness (upper horizontal gray dotted line) and the fitness achieved by the population mean (lower horizontal gray dotted line); (c) the trait
experiences sex-specific selection but has evolved sexual dimorphism, the population therefore experiences a reduced gender-load; (d) the trait
experiences sex-specific selection but since the extent of sexual dimorphism matches the fitness optima, the gender-load has been eliminated.
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lection on the trait does become sex-specific, then the
trait enters the second stage, where constraints in the
genetic architecture of the trait may prevent it from
becoming sexually dimorphic (Figure 2b). This may be
because the trait exhibits a perfect intersexual genetic
correlation (rMF = 1) or because the genes underlying
the trait function in other contexts (i.e. pleiotropically)
and thereby constrain evolutionary change [19-21]. The
constraint to evolutionary change has important conse-
quences for a population experiencing sexually antagonistic
selection. In effect, the mean trait value of either sex is dis-
placed from its optima. This population level shortfall in
fitness has been termed the sexual dimorphism, or gender-
load [22], which has been empirically demonstrated byexperimental evolution studies, e.g. [23]. The gender-load
will be at its greatest for traits in this second stage, i.e.
when they are sexually monomorphic but experience sex-
specific selection pressures [24], assuming the sex-specific
optima do not later change.
The third stage occurs when the genetic architecture of
the trait allows it to evolve some limited degree of sexual
dimorphism, i.e. the gender-load is not diminished entirely
(Figure 2c). The changes in trait architecture between the
sexes allow a relaxation of the intersexual genetic correl-
ation (rMF <1). There are several proposed mechanisms by
which the genetic architecture of a shared trait can be-
come at least partially sex-specific. These include the
evolution of sex-specific epigenetic imprinting ([25], e.g.
sex-dependent methylation [26]), sex-linked modifiers
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scripts [27], plus more major genetic modifications
such as gene duplication [28,29] or translocation to sex-
chromosomes [30]. There is some evidence in support of
some [16,19,31] but not all [32], and it is not clear which
ones predominate or whether there are other mechanisms.
More complex possibilities, such as sex-specific imprint-
ing that influences the dynamics of epistatic loci [33], have
not been investigated empirically.
The final stage occurs when the mean phenotypic
value of the trait in both sexes is aligned with the sex-
specific optimal trait values (Figure 2d). At this stage,
the gender-load is eliminated and no further trait evolu-
tion is predicted, since although selection is sex-specific,
it acts in a stabilizing manner in both sexes. Full reso-
lution of sexual antagonism may not be possible for a
variety of reasons, and it is not known how common full
resolution is. For example, evidence from Drosophila
melanogaster indicates that while the vast majority of
gene transcripts are sex-biased, only a minority of these
show sexually antagonistic patterns of expression [34],
indicating conflict resolution may be widespread at least
in adult stages.
The evolutionary transitions between these four stages
will not necessarily always be one way, from early to
later stages, as reversals seem plausible. For example, if
selection pressures on the focal or genetically correlated
traits change due to environmental parameters changing.
Furthermore, the rate at which traits evolve to become
sexually dimorphic, thereby resolving the conflict, is not
known [35], although some of the mechanisms for con-
flict resolution require extensive revisions to the genetic
architecture and may take considerable periods of time
to occur (e.g. gene duplications, translocations). Finally,
such major changes to the genetics may mean that a
trait does not experience all four stages, since it is likely
that the form and strength of selection that a trait expe-
riences may also change radically following gene dupli-
cation or translocation to a sex chromosome.
It should also be noted that this evolutionary model is
univariate—taking a single trait and predicting its evolu-
tionary trajectory based on its genetic architecture and
how selection acts upon it. In reality, traits do not occur
in isolation but form part of a multivariate space of quan-
titative traits. As a consequence, the evolutionary trajec-
tories that can be predicted are likely to be modified due
to constraints imposed upon them by a considerably more
complex genetic architecture [21].
Sex-specific genetics and disease
Darwin discriminated between the effects of sexual and
natural selection, suggesting that the evolution of sexual
dimorphism via sexual selection was maladaptive [10], in
the sense that it appeared to favour the evolution ofunwieldy or costly traits that could not have evolved via
natural selection. Darwin’s framework therefore impli-
citly includes the concept of a gender-load and the po-
tential for sexually dimorphic adaptations to be harmful
in some way to an individual’s fitness, in terms of repro-
ductive output or survival. The link between loss of fit-
ness and disease is not direct in this case and Darwin
himself never made that link explicitly. It is also not
clear whether he considered the possibility that a gender
load (or equivalent concept) could arise due to sex-
specific natural selection.
By definition, sexually antagonistic alleles experience
purifying selection in one sex by reducing survival or re-
productive output and may do so by contributing to an
individual’s overall propensity to develop disease. More
generally, current population genetic theory predicts that
alleles with either sex-specific or sexually antagonistic
effects on Darwinian fitness can achieve higher frequen-
cies as well as account for a greater proportion of gen-
etic variance than alleles with symmetrical deleterious
effects [7]. Genetic variants with sex-specific effects could
therefore be important determinants of disease predispos-
ition and as a result, sex is likely to be an important factor
to consider when exploring the underlying causative loci
of disease [5,24].
In cases where selection is sex-limited (i.e. purifying se-
lection only operates in one sex (see [23] for an experi-
mentally enforced version) either because the trait is only
expressed in one sex or because the pattern of inheritance
is sex-limited), then the genome is expected to accumulate
mutations with sex-specific effects. There is some evi-
dence of this process occurring in the D. melanogaster
mitochondrial genome [36], where thanks to its pattern of
maternal inheritance, a sex-specific selective sieve is pre-
dicted to result in the accumulation of mutations that are
deleterious to males only (so-called ‘Mother’s curse’ [37]).
A recent study in humans has also found evidence for a
similar effect at autosomal loci [38], where genes with
highly male-specific (essentially sex-limited) patterns of
expression showed twice as many deleterious alleles as
those expressed in both sexes. This empirical evidence
supports evolutionary models that predict higher popula-
tion frequencies for alleles experiencing asymmetric selec-
tion pressures across the sexes [7]. These models also
predict equilibrium frequencies for sexually antagonistic
alleles to be even higher than for sex-limited alleles [7].
One way of detecting the signal of genes with sex-
specific effects is to examine sex-specific trait heritabilities,
that is defined within a quantitative genetic framework as
the proportion of phenotypic variance within a sample of
individuals of one sex that can be accounted for by differ-
ences between genotypes, i.e. genetic variation [39]. In the
absence of any loci with sex-specific effects and assuming
a common environment, heritability estimates should not
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may indicate the existence of genes with sex-specific gen-
etic effects and sex-specific genetic architecture. A recent
review of estimates in humans indicates sex-specific heri-
tabilities are common for a range of traits, although not a
universal feature [24].
Heritability estimates however are only a snapshot of
genetic and phenotypic variance present within a popu-
lation at a single point in time. As such, they may not be
a reliable indicator of sex-specific effects or may miss
more subtle or complex genetic effects (such as mater-
nal, dominance or epistatic effects in the case of narrow
sense heritability, which is based only on additive genetic
effects), and similar heritability estimates may be obtained
even when the genetic architecture differs between the
sexes. More convincing evidence would be if individual
loci demonstrated sex-specific effects on phenotypes. In
fact, recently, there has been a surge of discoveries from
genome-wide association studies (GWAS) that have iden-
tified loci with sex-specific effects [24], (see below).
Sexually dimorphic human quantitative traits and diseases
Pathologies of sex-limited traits are obvious examples of
sex differences in disease; being absent entirely in one sex.
More generally, there is clear evidence for widespread sex-
ual dimorphism for a range of common diseases, as well
as several human morphological, behavioural and physio-
logical parameters (as any issue of Biology of Sex Differ-
ences will testify). These include cardiovascular disease,
asthma, autoimmune diseases, some neurological and psy-
chiatric disorders, as well as some common birth defects
and cancers [5].
As I outlined in the introduction, sex differences in
disease may in part be attributable to underlying sex
differences in circulating hormones or other sexually
dimorphic traits. For example, body musculature in
humans is a sexually dimorphic trait that arises due to
sex differences in the levels of circulating hormones
during puberty [40]. The dimorphism in this morpho-
logical trait has functional repercussions, where reduced
muscle strength relative to body mass in women increases
their risk of developing knee osteoarthritis, a pattern not
seen in men [41].
There is nonetheless, evidence that some genetic fac-
tors contributing to human quantitative traits or disease
risk act in sex-specific ways. A recent review of GWAS
hits identified 33 autosomal loci having sex-specific
effects on 22 traits including quantitative traits such as
waist-height ratio and blood lipid levels, as well as
Crohn’s disease and type II diabetes [24]. The majority
of these loci were sex-limited in their effects, with a
smaller number having sex-asymmetric effects. It is worth
highlighting that the majority of these are quantitative
traits not disease phenotypes. However, since the mostpowerful analytical approaches for investigating sex-
specific genetic effects are only recently being imple-
mented [24], the number of loci having sex-specific
effects on disease is likely to expand. The influence of
sex on disease penetrance has also been reviewed by
Cooper et al. [42], which contains further examples.
However, detecting sex-specific loci is likely to be a
methodological challenge, in part because it is in essence
an interaction effect, which usually requires larger sam-
ple sizes to achieve sufficient statistical power [24,43].
The complex mixture of factors contributing to disease
risk further complicates the endeavour. For example, like
many common diseases, the risk of developing cardio-
vascular disease is dependent on a number of environ-
mental and genetic factors. It shows sex-specific patterns
of prevalence [5], which may be dependent on hormonal
effects (male-biased until the menopause, then becoming
female-biased), but risk is also dependent on environmen-
tal factors (such as diet and exercise) and other traits for
which sex-specific genetic effects have been identified (e.g.
low- and high-density lipoprotein; body fat composition).
Obtaining a full picture of how sex-specific selection on
all these factors combine into one overall risk score is
therefore unlikely to be straightforward.
None of the loci identified so far exhibit sexually an-
tagonistic effects, i.e. being a risk factor for one sex but
protective for the other. An interesting case however
comes from the Drosophila model, where there is some
evidence that the tumor suppressor p53 is a locus that
experiences sexually antagonistic selection [44], since its
expression reduces life span in females but extends life
span in males, with the effects being dependent upon
developmental stage and environmental factors [45].
Sexual antagonism in humans
Evidence of sex-specific or sexually antagonistic selec-
tion on shared traits in humans is also scant; in part this
may be due to the difficulty in obtaining appropriate data.
One example however is height, which for females in
western societies is under negative selection [46], whereas
for males selection is curvilinear, meaning that men of
intermediate height achieve highest lifetime reproductive
success ([47], see also [48]). Selection on height is there-
fore sexually antagonistic. Furthermore, Stulp et al. [49]
were able to show that there is sexually antagonistic
genetic variation for height within their study popula-
tion. Human height is a sexually dimorphic trait and so
the evidence that it also experiences sexually antagonis-
tic selection raises the question of why height does not
evolve to become more sexually dimorphic, thereby re-
solving the conflict and eliminating the gender-load?
One possible explanation is that the large number of
loci segregating for variation in height [50,51] makes it
difficult for a sex-specific genetic architecture to evolve
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individual loci.
An alternative explanation is that since height is genetic-
ally correlated with other traits that experience different
selection pressures, these genetic correlations constrain
the evolution of greater sexual dimorphism [48]. A multi-
variate analysis of height and other size-related traits indi-
cated that there was a negative genetic correlation with
height in females and total cholesterol in males [48]. This
indirect negatively pleiotropic relationship could therefore
act as a constraint on the evolution of both traits in the
two sexes. The complex nature of the genetic architecture
of many traits may therefore hinder the resolution of sex-
ual antagonism [19].
A second line of evidence comes from a Finnish longi-
tudinal study where although phenotypic selection over
the timing and rate of reproduction were found to be di-
vergent between the sexes, the genetic correlations for
these traits with fitness were not [52]. These results
therefore suggest that no further sexual dimorphism is
expected to evolve for these traits in this population.
The authors suggest that cultural norms within this
traditional population, which enforce strict monogamous
sexual relationships, have constrained the variability in
reproductive success and therefore reduced the oppor-
tunity for genetic variation in reproductive success to be
expressed. This would mean that the genetic correlations
between the timing and rate of reproduction might have
been more divergent in populations where monogamy is
not culturally enforced.
Together these studies offer a rather patchy view of
sex-specific selection in human populations. They also
highlight the considerable difficulties in obtaining suit-
able data, the ideal being a multigenerational study with
a known pedigree and paternities, without strong cultural
constraints on reproductive success [52]. These kinds of
data may well already exist or possibly could be collated in
the future, with genomic technologies being applied at a
population scale combined with records of reproductive
success, but this will undoubtedly raise ethical dilemmas
if, for example, paternity is to be assigned based on gen-
etic data.
Conclusions
Evolutionary theory can provide a conceptual framework
within which sex differences in human physiological or
disease phenotypes can be understood. Sex differences
in themselves can act as risk factors for disease, but
there is increasing evidence that genetics plays a role in
contributing to quantitative traits and disease risk in
contemporary human populations. Although there are
no concrete examples at present of sexually antagonistic
loci contributing to disease risk, they are predicted to
occur at higher frequencies than alleles with sex-limitedeffects, for which there is already evidence. Furthermore,
while evidence that sexually antagonistic selection oper-
ates in humans is rare, there are recent examples that have
demonstrated both selection and genetic variation can be
sexually antagonistic. Overall, sex-specific and sexually an-
tagonistic selection is clearly relevant to our understand-
ing of the origins of human phenotypes, including disease,
and this understanding could provide particular benefits
to shaping therapies to the individual.
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